The involvement of intracerebral monoamines in the development of intracellular process in neocortex neurons.
Otellin
V A
VA
Department of Morphology, Institute of Experimental Medicine, Russian Academy of Medical Sciences, St. Petersburg.
Neokesariiskii
A A
AA
Korzhevskii
D E
DE
D015116:5,7-Dihydroxytryptamine / Q000494:pharmacology; D000818:Animals; D015306:Biogenic Monoamines / Q000502:physiology*; D001923:Brain Chemistry / Q000187:drug effects / Q000502:physiology*; D002946:Cisterna Magna; D004525:Efferent Pathways / Q000166:cytology / Q000254:growth & development / Q000502:physiology; D007150:Immunohistochemistry; D008297:Male; D008845:Microinjections; D019579:Neocortex / Q000166:cytology* / Q000254:growth & development* / Q000378:metabolism; D009474:Neurons / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D009498:Neurotoxins / Q000494:pharmacology; D019001:Nitric Oxide Synthase / Q000378:metabolism; D052248:Nitric Oxide Synthase Type I; D016627:Oxidopamine / Q000494:pharmacology; D017966:Pyramidal Cells / Q000187:drug effects / Q000502:physiology / Q000648:ultrastructure; D051381:Rats; D017208:Rats, Wistar; D018490:Serotonin Agents / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology
D015306:Biogenic Monoamines; D009498:Neurotoxins; D018490:Serotonin Agents; D013565:Sympatholytics; D015116:5,7-Dihydroxytryptamine; D016627:Oxidopamine; D019001:Nitric Oxide Synthase; D052248:Nitric Oxide Synthase Type I; C496322:Nos1 protein, rat